Autolus Therapeutics plc Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Autolus Therapeutics plc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Autolus Therapeutics plc Operating Lease, Payments for the quarter ending March 31, 2024 was $1.73M, a 33.1% increase year-over-year.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2023 was $10.4M, a 127% increase from 2022.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2022 was $4.58M, a 0.95% decline from 2021.
  • Autolus Therapeutics plc annual Operating Lease, Payments for 2021 was $4.62M, a 5.66% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.4M +$5.83M +127% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $4.58M -$44K -0.95% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $4.62M -$277K -5.66% Jan 1, 2021 Dec 31, 2021 20-F 2023-03-07
2020 $4.9M +$2.48M +103% Jan 1, 2020 Dec 31, 2020 20-F 2022-03-10
2019 $2.42M Jan 1, 2019 Dec 31, 2019 20-F 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.